CJEU: Melatonin Classification as Medicine in France Lawful

CJEU Judgment C-123/24

The CJEU ruled that France may classify melatonin products with >2 mg per daily dose as medicines, even if they are sold as food supplements in other EU countries.

Consequences

• No automatic mutual recognition of food supplements in the EU
• National authorities retain decision-making power
• Manufacturers must check country-specific regulations

Practical Tip

Check melatonin dosage in your products before exporting to France.